We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+24.71%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$866M
AUM Growth
+$149M
(+21%)
Cap. Flow
+$43.9M
Cap. Flow
% of AUM
5.07%
Top 10 Holdings %
Top 10 Hldgs %
7.14%
Holding
453
New
147
Increased
91
Reduced
74
Closed
130
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$4.71M |
| 2 |
GIMO
Gigamon Inc.
GIMO
|
+$4.45M |
| 3 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
+$4.39M |
| 4 |
SAAS
inContact, Inc.
SAAS
|
+$4.38M |
| 5 |
INN
Summit Hotel Properties
INN
|
+$4.32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESPR
Esperion Therapeutics
ESPR
|
+$6.11M |
| 2 |
IMPV
Imperva, Inc.
IMPV
|
+$5.46M |
| 3 |
RadNet
RDNT
|
+$5.41M |
| 4 |
PLNR
PLANAR SYSTEMS INC
PLNR
|
+$4.97M |
| 5 |
Motorcar Parts of America
MPAA
|
+$4.78M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.59% |
| 2 | Technology | 18.66% |
| 3 | Consumer Discretionary | 13.65% |
| 4 | Industrials | 11.89% |
| 5 | Communication Services | 5.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Omnicell
OMCL
$1.69B
| – | – |
-75,219
| Closed | -$2.49M |
|
377
OneSpan
OSPN
$588M
| – | – |
-136,790
| Closed | -$3.86M |
|
378
OraSure Technologies
OSUR
$286M
| – | – |
-112,578
| Closed | -$1.14M |
|
379
Puma Biotechnology
PBYI
$391M
| – | – |
-10,379
| Closed | -$1.96M |
|
380
Pacira BioSciences
PCRX
$1.06B
| – | – |
-20,604
| Closed | -$1.83M |
|
381
Piper Sandler
PIPR
$5.13B
| – | – |
-76,004
| Closed | -$1.1M |
|
382
CarParts.com
PRTS
$44.2M
| – | – |
-7,275
| Closed | -$170K |
|
383
FreightCar America
RAIL
$270M
| – | – |
-78,177
| Closed | -$2.06M |
|
384
Radcom
RDCM
$169M
| – | – |
-53,528
| Closed | -$649K |
|
|
385
RadNet
RDNT
$5.25B
| – | – |
-633,581
| Closed | -$5.41M |
|
386
Radware
RDWR
$1.16B
| – | – |
-38,194
| Closed | -$841K |
|
|
RGLS
387
DELISTED
Regulus Therapeutics
RGLS
| – | – |
-499
| Closed | -$961K |
|
388
Simmons First National
SFNC
$3.48B
| – | – |
-54,660
| Closed | -$1.11M |
|
|
SNCR
389
DELISTED
Synchronoss Technologies
SNCR
| – | – |
-6,065
| Closed | -$2.29M |
|
390
Steris
STE
$22.7B
| – | – |
-49,793
| Closed | -$3.23M |
|
391
Strategic Education
STRA
$1.89B
| – | – |
-14,367
| Closed | -$1.07M |
|
392
STRATTEC Security
STRT
$363M
| – | – |
-15,275
| Closed | -$1.26M |
|
393
Standex International
SXI
$3.78B
| – | – |
-48,167
| Closed | -$3.72M |
|
394
Synaptics
SYNA
$4.16B
| – | – |
-28,674
| Closed | -$1.97M |
|
395
TriNet
TNET
$3.24B
| – | – |
-84,302
| Closed | -$2.64M |
|
396
Tempest Therapeutics
TPST
$14M
| – | – |
-8
| Closed | -$982K |
|
|
TRUE
397
DELISTED
TrueCar
TRUE
| – | – |
-103,826
| Closed | -$2.38M |
|
398
Universal Electronics
UEIC
$59.6M
| – | – |
-24,673
| Closed | -$1.6M |
|
399
Visteon
VC
$2.82B
| – | – |
-24,287
| Closed | -$2.6M |
|
400
Varonis Systems
VRNS
$4.73B
| – | – |
-373,545
| Closed | -$4.09M |
|
Similar funds
RWM
MCM
HP
OMG
RB
ICCFIA
WCM
TSS
EAM Investors's Q1 2015 Portfolio in Review
As of Q1 2015, EAM Investors held 453 positions worth $866M, up 21% from $717M the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
EAM Investors deployed $43.9M of net new capital in Q1 2015, opening 147 new positions and adding to 91 existing holdings. Its largest new stake was Cardiovascular Systems, Inc.: 136,844 shares worth $5.34M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 27% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Esperion Therapeutics, an estimated $6.11M trimmed.
- EAM Investors's largest Q1 2015 buy was Cardiovascular Systems, Inc.: 136,844 shares worth $5.34M.
- EAM Investors added most to NEVRO CORP. in Q1 2015, an estimated $3.15M increase.
- EAM Investors's biggest Q1 2015 reduction was Esperion Therapeutics, cutting an estimated $6.11M.
- EAM Investors fully exited Imperva, Inc. in Q1 2015, selling an estimated $5.46M.
- EAM Investors's ten largest holdings make up 7.1% of its $866M portfolio in Q1 2015.
- EAM Investors opened 147 new positions and closed 130 in Q1 2015.
- EAM Investors's portfolio value rose 21% quarter-over-quarter to $866M.
Based on EAM Investors's 13F filing for Q1 2015, filed 7 May 2015.